NASDAQ · Medical Distribution · USD

Akso Health Group (AHG) Stock Analysis

Akso Health Group (AHG) is a Medical Distribution stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

AHG

$1.27

+$0.04 (+3.53%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare AHG with… →

AHG Key Statistics

As of Oct 21, 2026

Trading

Open: $1.37
Previous Close: $1.23
Day's Range: 1.21–1.37
52-Week Range: 0.68–2.50
Volume: 4.81K
Beta: −1.01

Valuation

Market Cap: $1.09B
P/E Ratio: unprofitable
P/S ratio: 78.66
EPS (ttm): −0.03

Financials (FY)

Revenue (FY): $13.83M−6.40%
Net Income (FY): −$18.67M
Profit margin: −134.99%
Shares Outstanding: 854.04M
1-Year Return: −22.09%

Dividend and dates

Avg Volume: 107.46K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, AHG closed at $1.27, −22.09% over 1 year.

Akso Health Group (AHG) has a market capitalization of $1.09B.

In fiscal 2025, AHG reported revenue of $13.83M.

AHG Stock Return by Calendar Year

Akso Health Group (AHG) return since Nov 2017: what $10,000 became

1 year: $10,000 $7,791; −22.09%
5 years: $10,000 $1,389; −86.11%
Since Nov 2017: $10,000 $349; −96.51%

If you had invested $10,000 in Akso Health Group (AHG) at the close on November 3, 2017, the earliest close on record here, it would have been worth $349 at the close on October 21, 2026: −96.51% in total, −31.21% a year, with dividends reinvested, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

−77.07%+96.81%−22.56%

2017*201820192020202120222023202420252026*

Year	Return
2026 (partial year)	−22.56%
2025	+20.59%
2024	+83.78%
2023	+96.81%
2022	−77.07%
2021	−33.60%
2020	−11.94%
2019	−62.60%
2018	−76.35%
2017 (partial year)	−12.72%

As of October 21, 2026.

AHG Revenue and Earnings by Fiscal Year

FY ends March

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$13.83M	−$18.67M	−135.0%
2024	$14.78M	−$134.98M	−913.4%
2023	$2.41M	−$9.46M	−391.8%
2022	$13.18M	−$1.36M	−10.3%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$13.83M	−$11.32K	−$4.00M	−$18.67M	−135.0%
2024	$14.78M	−$281.53K	−$3.92M	−$134.98M	−913.4%
2023	$2.41M	$122.13K	−$8.64M	−$9.46M	−391.8%
2022	$13.18M	$1.27M	−$14.27M	−$1.36M	−10.3%

Annual figures as reported, in the company's reporting currency. As of March 31, 2026.

AHG Valuation vs Medical Distribution Median

Median of 11 stocks

Metric	AHG	Medical Distribution median	vs median
P/S ratio	78.66	0.38	205.3x the median
Profit margin	−134.99%	−4.73%	130.3 pts below

Medians across 11 Medical Distribution stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Analysis

Data-derived

Company Overview

Akso Health Group (AHG) is capitalised at $1.09B on the latest close. The company sits in the Healthcare sector, in the Medical Distribution industry. The company reports 12 employees.

Over the past 52 weeks the price has ranged from $0.68 to $2.50. AHG last closed at $1.27 on October 21, 2026. That is +$0.04 (+3.53%) against the previous close. The latest close sits 86.49% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $13.83M. That is −6.40% against the prior fiscal year, when revenue was $14.78M. The same year closed with a net loss of $18.67M. Profit margin runs at −134.99%. That is 130.3 percentage points below the Medical Distribution median of −4.73%. Trailing earnings per share are −0.03.

Across the 4 fiscal years on file, revenue moves from $13.18M in 2022 to $13.83M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 78.66. On price-to-sales that is 205.3 times the Medical Distribution median of 0.38. 11 Medical Distribution companies report these metrics, and the medians quoted come from that group.

The trailing one-year total return is −22.09%. Measured over 5 years, that is −32.61% a year compounded. The reported beta is −1.01. Daily returns over the trailing 9 years annualize to a volatility of 168.51%.

Growth & Income

The latest dividend on file for AHG dates from 2018.

2026 is still running; the total return is −22.56% year to date. The strongest complete calendar year on file is 2023 at +96.81%; the weakest is 2022 at −77.07%. Of the 8 complete calendar years on file, 3 finished higher.

Peer Comparison

Akso Health Group (AHG) operates in the Medical Distribution industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Akso Health Group	AHG	$1.09B	—
McKesson Corporation	MCK	$118.40B	27.2
Cencora, Inc.	COR	$64.96B	25.3
Cardinal Health, Inc.	CAH	$58.83B	35.1

The Medical Distribution industry average P/E ratio is 26.2x. Akso Health Group has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Distribution Stocks

MCK

McKesson Corporation

$118.40B

COR

Cencora, Inc.

$64.96B

CAH

Cardinal Health, Inc.

$58.83B

HSIC

Henry Schein, Inc.

$9.47B

FOCL

EDAP TMS S.A.

$206.34M

COSM

Cosmos Health Inc.

$28.25M

View all Medical Distribution stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

JNJ

Johnson & Johnson

$621.22B

ABBV

AbbVie Inc.

$503.27B

UNH

UnitedHealth Group Incorporated

$374.30B

MRK

Merck & Co., Inc.

$369.78B

View all Healthcare stocks →

About Akso Health Group

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as trading and technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

Visit website →